"Androstenols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Unsaturated androstanes which are substituted with one or more hydroxyl groups in any position in the ring system.
| Descriptor ID |
D000737
|
| MeSH Number(s) |
D04.210.500.054.079.429
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Androstenols".
Below are MeSH descriptors whose meaning is more specific than "Androstenols".
This graph shows the total number of publications written about "Androstenols" by people in this website by year, and whether "Androstenols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 2 | 0 | 2 |
| 2014 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Androstenols" by people in Profiles.
-
Mostaghel EA, Lin DW. Practical guide to the use of abiraterone in castration resistant prostate cancer. Can J Urol. 2014 Apr; 21(2 Supp 1):57-63.
-
Ryan C, Shore ND, Concepcion R. A urologic oncology roundtable discussion: how to choose among the available therapies for the treatment of castration-resistant prostate cancer. Postgrad Med. 2013 Nov; 125(6):114-6.
-
Shore ND, Concepcion R, Barocas DA. A urologic oncology roundtable discussion: the role of disease monitoring in treatment decision-making for patients with metastatic castration-resistant prostate cancer. Hosp Pract (1995). 2013 Oct-Nov; 41(4):78-80.
-
Gomella LG, Gelpi F, Kelly WK. New treatment options for castrate-resistant prostate cancer: a urology perspective. Can J Urol. 2011 Aug; 18(4):5767-77.
-
Iczkowski KA, Hertelendy F. Participation of the cytoskeleton in avian granulosa cell steroidogenesis. Gen Comp Endocrinol. 1991 Jun; 82(3):355-63.